Veracyte Inc VCYT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $24.00
- Day Range
- $22.50–24.99
- 52-Week Range
- $21.91–60.91
- Bid/Ask
- $24.00 / $24.55
- Shares Outstanding
- 80.70M
- Market Cap
- $1.94B
- Volume/Avg
- 7M / 2M
Key Statistics
- Price/Earnings (Normalized)
- 13.25
- Price/Sales
- 3.42
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 755
- Website
- https://www.veracyte.com
Valuation
Metric | VCYT |
|---|---|
Price/Earnings (Normalized) | 13.25 |
Price/Book Value | 1.36 |
Price/Sales | 3.42 |
Price/Cash Flow | 11.22 |
Price/Earnings
VCYT
Financial Strength
Metric | VCYT |
|---|---|
Quick Ratio | 5.07 |
Current Ratio | 5.56 |
Interest Coverage | — |
Quick Ratio
VCYT
Profitability
Metric | VCYT |
|---|---|
Return on Assets (Normalized) | 11.77% |
Return on Equity (Normalized) | 12.71% |
Return on Invested Capital (Normalized) | 11.51% |
Return on Assets
VCYT
Diagnostics & Research Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc TMO | LOCK|c$$s%xG | LOCK|#z | $257B | |||
| Danaher Corp DHR | LOCK|y@bHrY&G | LOCK|Jm> | $162B | |||
| IDEXX Laboratories Inc IDXX | LOCK|v%qB^&# | LOCK|T>? | $53B | |||
| Agilent Technologies Inc A | LOCK|##DW#%M | LOCK|&B | $49B | |||
| Waters Corp WAT | LOCK|JQ<q?< | LOCK|Clx | $45B | |||
| IQVIA Holdings Inc IQV | LOCK|^^G%<Bx | LOCK|#vT$H | $45B | |||
| Mettler-Toledo International Inc MTD | LOCK|rM!^>bv | LOCK|L!<gD | $34B | |||
| Illumina Inc ILMN | LOCK|#??P?l% | LOCK|%lGWT | $32B | |||
| Labcorp Holdings Inc LH | LOCK|W$Cl<#L | LOCK|%p$$ | $30B | |||
| Quest Diagnostics Inc DGX | LOCK|s@m>>hn | LOCK|%dvx? | $28B |
United States